8-K
Current Report
Neuronetics, Inc. Filed Acc 0001193125-20-105356
Exit or restructuring costs · Executive or director change
- Item 2.05 Costs associated with exit or disposal activities
- Item 5.02 Departure or appointment of directors or officers
From the SEC's structured data for this filing
Loading d919411d8k.htm…